Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $8.0 million.

  • Prokidney's Cash from Financing Activities rose 7865.8% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 9402.11%. This contributed to the annual value of $144.4 million for FY2024, which is 161196.73% up from last year.
  • Latest data reveals that Prokidney reported Cash from Financing Activities of $8.0 million as of Q3 2025, which was up 7865.8% from -$14000.0 recorded in Q2 2025.
  • Prokidney's Cash from Financing Activities' 5-year high stood at $507.5 million during Q3 2022, with a 5-year trough of -$9.5 million in Q4 2023.
  • Its 4-year average for Cash from Financing Activities is $46.1 million, with a median of -$8000.0 in 2022.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 11880000.0% in 2023, then surged by 107580769.23% in 2024.
  • Prokidney's Cash from Financing Activities (Quarter) stood at -$8000.0 in 2022, then crashed by 118800.0% to -$9.5 million in 2023, then surged by 101.29% to $123000.0 in 2024, then soared by 6372.36% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, -$14000.0 for Q2 2025, and -$12000.0 during Q1 2025.